Michael Morabito
Stock Analyst at Chardan Capital
(0.04)
# 4,399
Out of 5,008 analysts
9
Total ratings
11.11%
Success rate
-23.25%
Average return
Main Sectors:
Top Industries:
Stocks Rated by Michael Morabito
| Stock | Action | Price Target | Current | Upside | Ratings | Updated | |
|---|---|---|---|---|---|---|---|
| AKRO Akero Therapeutics | Maintains: Buy | $79 → $81 | $46.00 | +76.09% | 2 | Mar 17, 2021 | |
| MDGL Madrigal Pharmaceuticals | Maintains: Buy | $202 → $203 | $436.28 | -53.47% | 2 | Feb 26, 2021 | |
| ETNB 89bio | Maintains: Buy | $59 → $95 | $14.83 | +540.59% | 3 | Sep 15, 2020 | |
| VKTX Viking Therapeutics | Maintains: Buy | $15 → $20 | $31.54 | -36.58% | 2 | Aug 31, 2020 |
Akero Therapeutics
Mar 17, 2021
Maintains: Buy
Price Target: $79 → $81
Current: $46.00
Upside: +76.09%
Madrigal Pharmaceuticals
Feb 26, 2021
Maintains: Buy
Price Target: $202 → $203
Current: $436.28
Upside: -53.47%
89bio
Sep 15, 2020
Maintains: Buy
Price Target: $59 → $95
Current: $14.83
Upside: +540.59%
Viking Therapeutics
Aug 31, 2020
Maintains: Buy
Price Target: $15 → $20
Current: $31.54
Upside: -36.58%